1. Introduction 1.1 Study Deliverables 1.2 General Study Assumptions 2. Research Methodology 2.1 Introduction 2.2 Analysis Methodology 2.3 Study Phases 2.4 Econometric Modelling 3. Executive Summary 4. Market Overview and Trends 4.1 Introduction 4.2 Market Trends 4.3 Porter’s Five Force Framework 4.3.1 Bargaining Power of Suppliers 4.3.2 Bargaining Power of Consumers 4.3.3 Threat of New Entrants 4.3.4 Threat of Substitute Products and Services 4.3.5 Competitive Rivalry within the Industry 5. Market Dynamics 5.1 Drivers 5.1.1 Increasing Demand for Animal Products 5.1.2 Humanization of Pets 5.2 Restraints 5.2.1 Increasing Adoption of Vegan Diet 5.2.2 Cost Effective Production 5.3 Opportunities 5.3.1 Increase in Investment in R&D 6. Europe Veterinary Healthcare Market Segmentation, By Animal Type 6.1 Farm animal 6.1.1 Cattle 6.1.2 Swine 6.1.3 Poultry 6.1.4 Fish 6.1.5 Others 6.2 Companion Animal 6.2.1 Dog 6.2.2 Cat 6.2.3 Others 7. Europe Silage Inoculant Market Segmentation, By Country 7.1 United Kingdom 7.2 Germany 7.3 France 7.4 Russia 7.5 Spain 7.6 Italy 7.5 Rest of Europe 8. Competitive Landscape and Introduction 8.1 Introduction 8.2 Market Share Analysis 8.3 Developments of Key Players 9. Key Vendor Analysis (Overview, Products & Services, Strategies) 9.1 Zoetis animal healthcare 9.2 Merck 9.3 Merial (Animal Health Division of Sanofi) 9.4 Elanco 9.5 Bayer healthcare 9.6 Ceva Animal Health, Inc. 9.7 Virbac 9.8 Boehringer Ingelheim 10. Disclaimer

Zoetis animal healthcare,Merck,Merial (Animal Health Division of Sanofi),Elanco,Bayer healthcare,Ceva Animal Health, Inc.,Virbac,Boehringer Ingelheim